Nonetheless, 90 days of exposure of melanoma cells to BRAF inhibitors displays no multidrug resistance, leading to the elimination of IDTC markers such as NGFR and KDM5B and permanent resistance [174]. This evidence concerns the gene KDM5B and melanoma.